基于临床管理考虑,临床医生对多发性硬化症中神素-1-酸盐受体调节器的偏好:一种选择实验
Alexander Keenan1, Chiara Whichello2, Hoa H Le3
1Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. akeenan1@its.jnj.com.
神经学家更喜欢ponesimod治疗多发性硬化症 (MS) 由于更容易的临床管理,特别是更少的药物相互作用. 这一发现有助于MS治疗决策和患者与临床医生的讨论.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床决策 临床决策
背景情况:
- 在美国,有四种sphingosine-1-phosphate受体 (S1PR) 调节器可用于复发性多发性硬化症 (MS).
- 这些S1PR调节器表现出类似的疗效,需要考虑临床管理因素来选择治疗.
研究的目的:
- 根据临床管理偏好来估计S1PR调节器的选择.
- 量化个别临床管理方面对治疗选择的影响.
主要方法:
- 一个多标准决策分析 (MCDA) 使用一个离散选择实验 (DCE) 与200美国神经科医生.
- 评估了八个临床管理属性,包括药物相互作用,首剂量观察和免疫恢复时间.
主要成果:
- 波尼西莫德获得了最高的总体MCDA得分 (4.78),其次是西波尼莫德 (4.10),芬戈利莫德 (3.61) 和奥扎尼莫德 (2.38).
- 较少的药物相互作用,没有第一剂观察,较短的免疫恢复,没有胺食物相互作用是关键的偏好驱动因素.
结论:
- 波尼西莫德是美国神经科医生治疗多发性硬化症的首选S1PR调节器,基于临床管理方便性.
- 尽量减少药物相互作用是影响临床医生在选择多发性硬化症治疗方面的偏好最重要的因素.
更多相关视频
08:40Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Skeletal Muscle Relaxants: Therapeutic Uses
